Showing 261 - 280 results of 114,187 for search '(( i non decrease ) OR ( 5 ((((wt decrease) OR (we decrease))) OR (a decrease)) ))', query time: 1.86s Refine Results
  1. 261

    Stromal Expression of Decorin, Semaphorin6D, SPARC, Sprouty1 and Tsukushi in Developing Prostate and Decreased Levels of Decorin in Prostate Cancer by Alexander Henke (145303)

    Published 2012
    “…In P28 and adult prostates there was either a decrease in the expression (Semaphorin6D) or a switch to epithelial expression of SPARC, and Spry-1, whereas Decorin and Tsukushi were specific to mesenchyme/stroma at all ages. …”
  2. 262
  3. 263
  4. 264
  5. 265
  6. 266
  7. 267

    Different response of visASCs to a micro-local oxygen concentration decrease in metabolically active sites of the adipose tissue. by Wilfredo Oliva-Olivera (301968)

    Published 2017
    “…However, hypox-visASCs from MS patients show a lower ability to actively participate in or stimulate the formation of microvascular structures, while they favor the accumulation of CD11C<sup>+</sup> and CD163<sup>+</sup> macrophages in the adipose tissue through their contribution to the increased tissue levels of MCP1. ↑ Increased response; <b>↓</b> Decreased response; → Hypox-visASCs main response NonMS: obese subjects without metabolic syndrome; MS: obese subjects with metabolic syndrome; visASC: visceral adipose tissue-derived multipotent mesenchymal cells; hypox-visASCs: visASC under hypoxia; NOX5: NADPH Oxidase 5; SDF1α: stromal cell-derived factor 1α; VEGF: vascular endothelial growth factor; MCP1: monocyte chemoattractant protein 1; CD11C<sup>+</sup>, CD163<sup>+</sup>: proinflammatory macrophage cell-surface markers.…”
  8. 268
  9. 269

    Data_Sheet_1_Steroids Therapy in Patients With Severe COVID-19: Association With Decreasing of Pneumonia Fibrotic Tissue Volume.docx by Jin-wei He (5658988)

    Published 2022
    “…For example, after four CT cycles of treatment, the volume reduction percentage of PFT in the entire lung was −59.79[±12.4]% for the steroid-treated patients with severe illness, and its p-value was 0.000 compared to that (−27.54[±85.81]%) in non-steroid-treated ones. However, for the patient with a significant-severe illness, PFT reduction in steroid-treated patients was −41.92[±52.26]%, showing a 0.275 p-value compared to −37.18[±76.49]% in non-steroid-treated ones. …”
  10. 270

    Data Sheet 1_Aging of visual word perception is related to decreased segregation within and beyond the word network in the brain.docx by Licheng Xue (6683348)

    Published 2024
    “…</p>Methods<p>A total of 19 healthy older adults and 22 young adults were recruited to participate in two functional magnetic resonance imaging (fMRI) sessions (one resting-state session and one for localizer tasks), along with a visual word perceptual processing task. …”
  11. 271

    Data Sheet 1_Decreased cigarette smoking may partially explain the increased prevalence of antinuclear antibodies in the United States.pdf by Gregg E. Dinse (4500940)

    Published 2025
    “…</p>Results<p>Over the study periods, ANA prevalence was highest (13.3-19.2%) for nonsmokers but non-trending; lower (11.1-15.5%) for “passive” smokers but steadily increasing; and even lower for active smokers but increasing from 7.4% in 1999–2004 to 13.3% in 2011-2012. …”
  12. 272
  13. 273
  14. 274
  15. 275

    iNKTs are selectively decreased in obese livers. by Maya E. Kotas (203189)

    Published 2011
    “…<p>A) The percentage (left panel) of tetramer+, CD3ε-int iNKTs among total CD3ε+B220- lymphocytes is decreased in the liver but not the spleen of mice made obese through 6 months of HFD compared to controls, as is the absolute number of hepatic iNKTs (right panel) (n = 4 mice/group). …”
  16. 276
  17. 277
  18. 278

    Supplementary Material for: Enhanced Recovery after Surgery for Radical Cystectomy Decreases Postoperative Complications at Different Times by Lannes F. (11465377)

    Published 2021
    “…There was no significant difference between groups for 90-day readmission (<i>p</i> = 0.349). Mean length of stay did not differ significantly between ERAS and non-ERAS groups (12.7 ± 6.2 and 13.1 ± 5.7 days, respectively; <i>p</i> = 0.743). …”
  19. 279
  20. 280